Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and Adolescents.
Messiah SE, Swartz MD, Abbas RA, Talebi Y, Kohl HW 3rd, Valerio-Shewmaker M, DeSantis SM, Yaseen A, Kelder SH, Ross JA, Padilla LN, Gonzalez MO, Wu L, Lakey D, Shuford JA, Pont SJ, Boerwinkle E. Messiah SE, et al. Among authors: kelder sh. Children (Basel). 2023 Apr 30;10(5):818. doi: 10.3390/children10050818. Children (Basel). 2023. PMID: 37238366 Free PMC article.
Incorporating primary and secondary prevention approaches to address childhood obesity prevention and treatment in a low-income, ethnically diverse population: study design and demographic data from the Texas Childhood Obesity Research Demonstration (TX CORD) study.
Hoelscher DM, Butte NF, Barlow S, Vandewater EA, Sharma SV, Huang T, Finkelstein E, Pont S, Sacher P, Byrd-Williams C, Oluyomi AO, Durand C, Li L, Kelder SH. Hoelscher DM, et al. Among authors: kelder sh. Child Obes. 2015 Feb;11(1):71-91. doi: 10.1089/chi.2014.0084. Epub 2015 Jan 2. Child Obes. 2015. PMID: 25555188 Free PMC article.
Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey.
Valerio-Shewmaker MA, DeSantis S, Swartz M, Yaseen A, Gonzalez MO, Kohl HWI, Kelder SH, Messiah SE, Aguillard KA, Breaux C, Wu L, Shuford J, Pont S, Lakey D, Boerwinkle E. Valerio-Shewmaker MA, et al. Among authors: kelder sh. Front Public Health. 2021 Dec 14;9:753487. doi: 10.3389/fpubh.2021.753487. eCollection 2021. Front Public Health. 2021. PMID: 34970525 Free PMC article. Clinical Trial.
Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents.
Messiah SE, DeSantis SM, Leon-Novelo LG, Talebi Y, Brito FA, Kohl HW, Valerio-Shewmaker MA, Ross JA, Swartz MD, Yaseen A, Kelder SH, Zhang S, Omega-Njemnobi OS, Gonzalez MO, Wu L, Boerwinkle E, Lakey DL, Shuford JA, Pont SJ. Messiah SE, et al. Among authors: kelder sh. Pediatrics. 2022 Jun 1;149(6):e2021055505. doi: 10.1542/peds.2021-055505. Pediatrics. 2022. PMID: 35301530 No abstract available.
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey.
Swartz MD, DeSantis SM, Yaseen A, Brito FA, Valerio-Shewmaker MA, Messiah SE, Leon-Novelo LG, Kohl HW, Pinzon-Gomez CL, Hao T, Zhang S, Talebi Y, Yoo J, Ross JR, Gonzalez MO, Wu L, Kelder SH, Silberman M, Tuzo S, Pont SJ, Shuford JA, Lakey D, Boerwinkle E. Swartz MD, et al. Among authors: kelder sh. J Infect Dis. 2023 Jan 11;227(2):193-201. doi: 10.1093/infdis/jiac167. J Infect Dis. 2023. PMID: 35514141 Free PMC article.
Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents.
Messiah SE, Hao T, DeSantis SM, Swartz MD, Talebi Y, Kohl HW 3rd, Zhang S, Valerio-Shewmaker M, Yaseen A, Kelder SH, Ross J, Gonzalez MO, Wu L, Padilla LN, Lopez KR, Lakey D, Shuford JA, Pont SJ, Boerwinkle E. Messiah SE, et al. Among authors: kelder sh. Pediatr Infect Dis J. 2022 Oct 1;41(10):e409-e417. doi: 10.1097/INF.0000000000003653. Epub 2022 Aug 1. Pediatr Infect Dis J. 2022. PMID: 35939608
171 results